In this study, the susceptibilities of 35 multidrug-resistant (MDR) Mycobacterium tuberculosis clinical isolates to second-line drugs, including kanamycin (KM), rifabutin (RBU), ofloxacin (OFX), p-aminosalicylic acid (PAS), capreomycin (CAP), clofazimine (CFM), and ethionamide (ETH), were investigated on blood agar according to CLSI recommendations. Compared with the results of the Bactec 460 TB system, agreement was 100, 100, 97, 100, 100, 100, and 86% for KM, RBU, OFX, PAS, CAP, CFM, and ETH, respectively. Compared with the results of the proportion method, agreement was 100, 100, 97, 100, 97, 100, and 77% for KM, RBU, OFX, PAS, CAP, CFM, and ETH, respectively.
Multidrug-resistant tuberculosis (MDR-TB) and extensively drug-resistant tuberculosis (XDR-TB) are major public health problems, especially in developing countries (13, 18, 21) . Rapid susceptibility testing is critical for early diagnosis of MDR-and XDR-TB and the initiation of effective regimens (14) . The agar proportion method performed on Middlebrook 7H10 and 7H11 agars is the reference method for susceptibility of Mycobacterium tuberculosis according to CLSI recommendations (16) . The Bactec 460 TB system (Becton Dickinson Diagnostic Systems, Sparks, MD), Bactec MGIT 960 (Becton Dickinson Diagnostic Systems, Sparks, MD), and Versa TREK system (formerly known as ESP II; Trek Diagnostic Systems, West Lake, OH) are cleared for used by the U.S. FDA for testing M. tuberculosis susceptibility to first-line drugs (16) . It has recently been demonstrated that blood agar can be used for routine culture and testing of M. tuberculosis susceptibility to first-line drugs (1-4, 6, 7, 15) .
In this study, the susceptibilities of 35 MDR M. tuberculosis clinical isolates against the second-line drugs kanamycin (KM), rifabutin (RBU), ofloxacin (OFX), p-aminosalicylic acid (PAS), capreomycin (CAP), clofazimine (CFM), and ethionamide (ETH) were investigated on blood agar, and results were compared to those obtained using the Bactec 460 TB system and the proportion method on Middlebrook 7H10 agar, performed according to CLSI recommendations.
Clinical MDR-TB strains were obtained from the Istanbul Faculty of Medicine, Department of Microbiology and Clinical Microbiology, Istanbul, Turkey. Isolates were identified by the Bactec NAP test as M. tuberculosis complex. Susceptibility to first-line drugs was determined by the radiometric method (Bactec 460 TB system) (19, 20) . M. tuberculosis H37Rv was used as a control strain. All drugs were obtained from the manufacturers in a chemically pure form. Stock antibiotic solutions and subsequent dilutions were prepared. All stock solutions except CFM, which was stored in the dark at room temperature, were stored at Ϫ70°C in small aliquots.
The agar proportion method using Middlebrook 7H10 and blood agar was performed with concentrations of 10, 5, 5, 1, 2, 1, and 2 g/ml for CAP, ETH, KM, CFM, OFX, RBU, and PAS, respectively (9, 10, 12, 16, 17) .
Middlebrook 7H12 broth (Bactec 12B; Becton Dickinson Microbiology Systems) was used for radiometric testing (5, 11, 16, 19, 20) . Second-line drugs (KM, RBU, PAS, CAP, CFM, OFX, and ETH) were tested by using single critical concentrations. Concentrations of second-line drugs tested in the Bactec 460 TB system were 1.25, 1.25, 5, 0.5, 2, 0.5, and 4 g/ml for CAP, ETH, KM, CFM, OFX, RBU, and PAS, respectively (9, 10, 12, 16, 17) .
The inoculum was prepared from freshly grown colonies on Löwenstein-Jensen medium. The supernatant of each isolate was adjusted to a 1 McFarland standard. The agar proportion method was performed on both Middlebrook 7H10 agar and blood agar (infusion agar, Becton Dickinson) separately according to CLSI recommendations (16) . The plates were monitored twice a week by the naked eye. Resistance was defined as growth of a colony count of Ͼ1% on drug-containing quadrants in comparison to drug-free quadrants (16) .
The Bactec 460 TB system revealed that all isolates were susceptible to KM and CFM. RBU, OFX, PAS, CAP, and ETH resistance was detected in 27, 1, 3, 2, and 17 isolates, respectively. All isolates were susceptible to KM and CFM on Middlebrook 7H10 agar; resistance was detected in 27, 1, 3, 1, and 14 isolates for RBU, OFX, PAS, CAP, and ETH, respectively. On blood agar, all isolates were susceptible to KM and CFM; resistance was detected in 27, 2, 3, 2, and 22 isolates for RBU, OFX, PAS, CAP, and ETH, respectively.
Blood agar results were compared with the results obtained using the Bactec 460 TB system and the proportion method on Middlebrook 7H10 agar. Agreement, sensitivity, specificity, positive predictive value, and negative predictive value are shown in Tables 1 and 2 . The results of susceptibility testing were obtained on the 21st day of incubation by the proportion method on blood and Middlebrook 7H10 agar as recommended by the CLSI. The results of susceptibility testing by the Bactec 460 TB system were obtained on the 5th day of incubation for 31 isolates and on the 8th day for 4 isolates.
Recently, it has been reported that blood agar could be used for the isolation of M. tuberculosis from clinical isolates (6, 7, 15) . In 2003, Drancourt et al. (6) reported that M. tuberculosis grows on blood agar within 1 to 2 weeks. Moreover, they emphasized that it is a time-saving, cost-effective, more sensitive method and at least as rapid as the automated method. performance of sheep blood and human blood agar for testing the susceptibility of M. tuberculosis to INH using the proportion method. Their results were obtained on incubation days 6 to 8 in both media; they showed that both media can be used as an alternative medium for the susceptibility testing of M. tuberculosis.
To the best of our knowledge, there is no report which tests the performance of blood agar in determining the susceptibility of M. tuberculosis against second-line drugs. The results of the present study demonstrated that blood agar may be useful as an alternative medium for determining the susceptibility of M. tuberculosis clinical isolates to second-line drugs (except ETH). Coban et al. (4) determined the susceptibilities of M. tuberculosis to first-and second-line antituberculosis drugs by the Etest by using different media, including 7H11, blood, and chocolate agars. They noted that chocolate agar showed insufficient growth, while results on blood agar were comparable to those on Middlebrook 7H11 agar.
In conclusion, susceptibility testing results of M. tuberculosis strains against second-line drugs, except ETH, on blood agar showed excellent agreement compared with two gold standard methods. A limitation of this study is that the majority of tested M. tuberculosis isolates were not resistant to second-line drugs. Further studies with more resistant strains are needed before the implementation of blood agar for susceptibility testing of M. tuberculosis strains against second-line drugs in diagnostic laboratories.
